Scientist II
Perrigo
Amit Bansal is currently working as a scientist in a Perrigo Company located at Michigan, USA since Oct’ 2018. He did his PhD from Mercer University School of Pharmacy and MS in pharmaceutical sciences from Temple University and Panjab University. He also worked for two years in generic multinational company in India (Ranbaxy Lab Ltd. & Jubilant Organosys)
During MS program at Panjab University, he worked on the development of nanoparticulate and solid oral dosage forms. While pursing MS at Temple University, he worked on polymer modification and development of solid dispersion for class II and IV drugs. His research work at Mercer University focused on the development of alternative treatment in the management of type 1 diabetes mellitus. He also worked on development and evaluation of nanovaccine as delivery vehicle administered through IM and skin route, thereby achieving a sustained release of the vaccine with the aid of biodegradable polymers. This culminates in achieving robust immune response and thus provides protection from rabies virus infection. He presented his research work through posters and oral presentation on various national and international forums. He has published a total of 13 publications.
Amit Bansal